Replies to post #7028 on Revance Therapeutics Inc (RVNC)

[go seek]

I’m sure the data presented are positive for Daxxi and Revance, but this data won’t move the stock.

[DewDiligence]

Those are ancillary data on retreatment intervals from the ASPEN-1 and ASPEN–OLS trials. Worth knowing, but not market-moving.